Nicholas Meanwell

49PUBLICATIONS
87CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designMolecular targetsMedical molecular engineering of nucleic acids and proteinsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 20, 2026
Some Recent Observations on the Role of Carbon Tetrel Bonding in Drug Design.

|Feb 20, 2026
Structural Aspects of Proline Methanologues in Drug Design, Optimization, and Development.

Stephen Hanessian, Nicholas A Meanwell

|Oct 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408.

Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier

|Aug 05, 2025
A Data-Driven Perspective on Bioisostere Evaluation: Mapping the Benzene Bioisostere Landscape with BioSTAR.

Pol Hernández-Lladó, Nicholas A Meanwell, Angela J Russell

|Nov 20, 2024
Invention of VH-937, a Potent HIV-1 Maturation Inhibitor with the Potential for Infrequent Oral Dosing in Humans.

Sing-Yuen Sit, Yan Chen, Jie Chen

|Oct 26, 2024
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.

Brian McAuliffe, Paul Falk, Jie Chen

Pageof 9

Frequent Collaborators

6 joint publications

Gunda I Georg

6 joint publications

Murugaiah A M Subbaiah

5 joint publications

Alicia Regueiro-Ren

4 joint publications

T G Murali Dhar